12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lower dose submicron diclofenac regulatory update

Iroko said FDA accepted for review an NDA for lower dose submicron diclofenac to treat mild to...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >